The article also touches on the public health impact of wildfires in Los Angeles, stressing healthcare systems and causing evacuations. In digital health, Nvidia announced collaborations to develop AI solutions in genomics and cancer treatment. Medtech advancements include FDA clearance for AI diagnostic tools and the commercial launch of Cresilon's Traumagel. The biotech and pharma sectors are seeing significant venture capital activity, with new funds and startups focusing on innovative treatments and technologies. Additionally, the article notes potential challenges for hospitals in 2025, leadership changes at the FDA, and a surge in dementia cases in the U.S.
Key takeaways:
- The J.P. Morgan Healthcare Conference in San Francisco saw significant dealmaking, including Johnson & Johnson's $14.6 billion acquisition of Intra-Cellular Therapies and Eli Lilly's $2.5 billion deal for Scorpion Therapeutics.
- Moderna is leading the development of a norovirus vaccine using mRNA technology, with a potential market value of $3 to $5 billion.
- Wildfires in Los Angeles have caused significant public health concerns and disruptions to healthcare services, with hospitals preparing for potential evacuations.
- Nvidia announced healthcare collaborations at the J.P. Morgan conference, including partnerships with IQVIA, Illumina, and the Mayo Clinic to develop AI solutions for healthcare.